This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

May 14-17, 2024 | In-Person + Digital
Boston, MA, USA,
Hynes Convention Center

Industry’s Largest & Most Renowned Event to Accelerate Your Oligo and Peptide Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency

See you in Boston next year May 14-17, 2024 | In-Person + Digital

Big Waves at TIDES USA 2023

Onsite highlights from TIDES USA 2023 - the biggest TIDES event EVER

Session Content On ConnectMe Until May 29th - Then Migrates to Streamly for 1 Year

Enjoy all the features of ConnectMe until May 29th. Then recorded sessions will migrate to Streamly and you will be emailed your login details in the coming week.

ACCESS NOVEL SCIENCE ACROSS THE ENTIRE OLIGONUCLEOTIDE, PEPTIDE, AND MRNA SPECTRUM

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES USA program features concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. Your registration provides access to the presentations across all 4 tracks, allowing you to create your own customized agenda.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics/Vaccines & Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies, and learn about state-of-the-art technologies for genome editing applications and hear about progress in genome editing delivery

Drug Delivery Innovations

Explore new technologies and approaches in the delivery of macromolecular therapeutics featuring multiple case studies of the delivery of oligonucleotides, peptides, mRNA therapeutics and genome editing delivery strategies. Learn about cutting-edge delivery advances including targeted delivery approaches for oligonucleotides, device-based delivery strategies and oral delivery of peptides.

TIDES Training Course Series

View the agenda for 3 Courses in 2023

Virtual Courses Covering: Conjugate Strategies, Introduction to Analytical Control, and Introduction to Oligonucleotide

Informa training courses provide in-depth teaching and discussion about highly technical and scientific topics relevant to the TIDES community that can not be covered at a conference. With 6+ hours of dedicated instruction in a classroom-like (teacher/student) environment, a training course will offer you interactive opportunities with the instructor and fellow attendees so you can get your most pressing questions answered in a much more individualized setting.

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. Our 2023 hybrid event will offer you the most flexibility needed during these uncertain times.

For more information, click the link below or email Mike Dunnet directly at mdunnet@informaconnectls.com.

Jesper Lau, Ph.D.

VP, Protein and Peptide Chemistry

Novo Nordisk, Denmark

The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them. I am thus delighted to learn that Informa Connect will deliver TIDES USA Boston 2020 in a virtual format, and I am convinced that a digital meeting will be extremely appreciated in order to continue the important global communication among the scientific communities during these tough times.